Ischemic protection and myofibrillar cardiomyopathy: Dose-dependent effects of in vivo δPKC inhibition

Circulation Research

Volumn 91, Issue 8, 2002, Pages 741-748

  Hahn, Harvey S ^a   Yussman, Martin G ^a   Toyokawa, Tsuyoshi ^a   Marreez, Yehia ^a   Barrett, Thomas J ^a   Hilty, K Chad ^a   Osinska, Hanna ^a   Robbins, Jeffrey ^a   Dorn II, Gerald W ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Congestive heart failure; Ischemia reperfusion; Myofibrillar cardiomyopathy; Protein kinase C

Indexed keywords

BETA CRYSTALLIN; DESMIN; MYOSIN HEAVY CHAIN; PROTEIN KINASE C DELTA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; MOUSE; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN STRUCTURE; TRANSGENIC MOUSE;

ANIMALS; CARDIOMYOPATHIES; CARDIOTONIC AGENTS; CELLS, CULTURED; CRYSTALLINS; CYTOSKELETON; DESMIN; ENZYME INHIBITORS; ISOENZYMES; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOSIN HEAVY CHAINS; ORGAN CULTURE TECHNIQUES; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN KINASE C-DELTA; SURVIVAL ANALYSIS;

EID: 0037131326     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000037091.64492.69     Document Type: Article

References (35)

1. Gu X, Bishop SP. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res. 1994;75:926-931.
2. Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg EO, Izumo S, Riegger G, Lorell BH. Angiotensin II-induced growth responses in isolated adult rat hearts: Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res. 1995;76:489-497.
3. 2+-sensitive isoforms in the failing human heart. Circulation. 1999;99:384-391.
4. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: Its role in ischemic preconditioning in the rat. Circ Res. 1994;75:586-590.
5. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu WJ, Teschner S, Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest. 1998;I01:2182-2198.
6. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986:233:305-312.
7. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995;9:484-496.
8. Newton AC. Protein kinase C: Structure, function and regulation. J Biol Chem. 1995;270:28495-28498.
9. Dom GW II, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, Mochly-Rosen D. Sustained in vivo cardiac protection by a rationally designed peptide that causes E protein kinase C translocation. Proc Natl Acad Sci U S A. 1999;96:12798-12803.
10. Mochly-Rosen D, Wu G, Hahn HS, Osinska H, Liron T, Lorenz JN, Yatani A, Robbins J, Dorn GW II. Cardiotrophic effects of protein kinase C ε: Analysis by in vivo modulation of PKCε translocation. Circ Res. 2000;86:1173-1179.
11. Wu G, Toyokawa T, Hahn HS, Dorn GW II. εprotein kinase C in pathological myocardial hypertrophy. J Biol Chem. 2000;39:29927-29930.
12. Chen L, Hahn HS, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW II, Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of δ PKC and ε PKC. Proc Natl Acad Sci U S A. 2001;98:11114-11119.
13. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy: A skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Eng J Med. 2000;342:770-780.
14. Vicart P, Caron A, Guicheney P, Li Z, Prévost MC, Faure A, Chateau D, Chapon F, Tomé F, Dupret JM, Paulin D, Fardeau M. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998;20:92-95.
15. Johnson JA, Gray MO, Chen CH, Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem. 1996;271:24962-24966.
16. Subramaniam A, Gulick JU, Neumann J, Knotts S, Robbins J. Transgenic analysis of the thyroid-responsive elements in the α-cardiac myosin heavy chain gene promoter. J Biol Chem. 1993;268:4331-4336.
17. Rindt H, Subramaniam A, Robbins J. An in vivo analysis of transcriptional elements in the mouse α-myosin heavy chain promoter. Transgenic Res. 1995;4:397-405.
18. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinska H, Hewett TE, Boivin G, Gulick J, Ng WA, Robbins J. Ablation of the murine α myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest. 1996;98:1906-1917.
19. D'Angelo D, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dom GW II. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A. 1997;94:8121-8126.
20. Dorn GW II, Robbins J, Ball N, Walsh RA. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol. 1994;267:H400-H405.
21. Dorn GW II, Mochly-Rosen D. Intracellular transport mechanisms of signal transducers. Annu Rev Physiol. 2002;64:407-429.
22. Bova MP, Yaron O, Huang Q, Ding L, Haley DA, Stewart PL, Horwitz J. Mutation R120G in αB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc Natl Acad Sci U S A. 1999;96:6137-6142.
23. Wang X, Osinska H, Dorn GW II, Nieman M, Lorenz JN, Gerdes AM, Witt S, Kimball T, Gulick J, Robbins J. Mouse model of desmin-related cardiomyopathy. Circulation. 2001;103:2404-2407.
24. Wang X, Osinska H, Klevitsky R, Gerdes AM, Nieman M, Lorenz JN, Hewett T, Robbins J. Expression of R120G-αB-crystallin causes aberrant desmin and αB-crystallin aggregation and cardiomyopathy in mice. Circ Res. 2001;89:84-91.
25. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation Of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J. 1991;5:3037-3046.
26. Ray PS, Martin JL, Swanson EA, Otani H, Dillmann WH, Das DK. Transgene overexpression of αB-crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J. 2001;15:393-402.
27. Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, Gerdes AM, Capetanaki Y. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol. 1999;31:2063-2076.
28. Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol. 1996;134:1255-1270.
29. Heling A, Zimmermann R, Kostin S, Maeno Y, Hein S, Devaux B, Bauer E, Klövekorn WP, Schlepper M, Schaper W, Schaper J. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res. 2000;86:846-853.
30. Owen PJ, Johnson GD, Lord JM. Protein kinase C-δ associates with vimentin intermediate filaments in differentiated HL60 cells. Exp Cell Res. 1996;225:366-373.
31. Goodnight J, Mischak H, Kolch W, Mushinski JF. Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts: Isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes. J Biol Chem. 1995;270:9991-10001.
32. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: A theme in signal transduction. Science. 1995;268:247-251.
33. Hodge CW, Mehmert KK, Kelly SP, McMahon T, Haywood A, Olive M, Wang D, Sanchez-Perez AM, Messing RO. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCε. Nat Neurosci. 1999;2:997-1002.
34. q interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998;280:574-577.
35. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice over expressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 1995;268:1350-1353.